Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
An unhealthy gut undermines absorption, increases systemic inflammation, and disrupts hormone signaling
Instead, stick to the basics: onion, carrot, celery, and garlic
WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported side effects include nausea, vomiting, diarrhoea, abdominal pain, and constipation
Vilsboll T, Agerso H, Krarup T, and Holst JJ
US$ 28.95
US$ 20.67
US$ 23.21
US$ 25.83
